cp-866,087
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2003 (NCT00147576)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Mu opioid receptorANTAGONIST
OPRM antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cp-866,087
- cp-866,087
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00482664 | Phase 2 | Jul 1, 2007 | Pfizer |
| NCT00479492 | Phase 2 | Jun 1, 2007 | Pfizer |
| NCT00147576 | Phase 2 | Dec 1, 2003 | Pfizer |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 3 | 3 | 1 | 2003 |
1 organizations
Page 1 / 1